<SEC-DOCUMENT>0000950170-25-009941.txt : 20250128
<SEC-HEADER>0000950170-25-009941.hdr.sgml : 20250128
<ACCEPTANCE-DATETIME>20250128170833
ACCESSION NUMBER:		0000950170-25-009941
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250128

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CG Oncology, Inc.
		CENTRAL INDEX KEY:			0001991792
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				371611499
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94327
		FILM NUMBER:		25565469

	BUSINESS ADDRESS:	
		STREET 1:		400 SPECTRUM CENTER DRIVE
		STREET 2:		SUITE 2040
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		(949) 419-6203

	MAIL ADDRESS:	
		STREET 1:		400 SPECTRUM CENTER DRIVE
		STREET 2:		SUITE 2040
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Unique Diamond Investments Ltd
		CENTRAL INDEX KEY:			0001991263
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		C/O ROOM NOS. 4727-4734
		STREET 2:		47/F, SUN HUNG KAI CENTRE
		CITY:			WAN CHAI HONG KONG
		STATE:			K3
		ZIP:			00000
		BUSINESS PHONE:		85238981505

	MAIL ADDRESS:	
		STREET 1:		C/O ROOM NOS. 4727-4734
		STREET 2:		47/F, SUN HUNG KAI CENTRE
		CITY:			WAN CHAI HONG KONG
		STATE:			K3
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001193125-24-182242</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001991263</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common stock, $0.0001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001991792</issuerCik>
        <issuerName>CG Oncology, Inc.</issuerName>
        <issuerCusip>156944100</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">400 Spectrum Center Drive, Suite 2040</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Irvine</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">92618</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Unique Diamond Investments Limited</reportingPersonName>
      <citizenshipOrOrganization>D8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>586982</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>586982</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>586982</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common stock, $0.0001 par value per share ("Common Stock") outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>ORI Healthcare Fund, L.P.</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>586982</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>586982</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>586982</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0.8</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>ORI Capital Inc.</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>586982</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>586982</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>586982</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>ORI Capital Holding Inc.</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>586982</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>586982</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>586982</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0.8</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Charming Jade Limited</reportingPersonName>
      <citizenshipOrOrganization>D8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>3003931</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>3003931</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>3003931</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>ORI Healthcare Fund II, L.P.</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>3003931</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>3003931</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>3003931</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>ORI Capital II Inc.</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>3003931</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>3003931</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>3003931</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>ORI Holding II Inc.</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>3003931</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>3003931</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>3003931</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Healthcare Seed Limited</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>3590913</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>3590913</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>3590913</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4.7</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>SONG, Hong Fang</reportingPersonName>
      <citizenshipOrOrganization>K3</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>4211341</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>4211341</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4211341</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.5</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>*This calculation is based on 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>CG Oncology, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>400 Spectrum Center Drive, Suite 2040, Irvine, California, 92618</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Unique Diamond Investments Limited
Charming Jade Limited
ORI Healthcare Fund, L.P.
ORI Healthcare Fund II, L.P.
ORI Capital Inc.
ORI Capital II Inc.
ORI Capital Holding Inc.
ORI Holding II Inc.
Healthcare Seed Limited
SONG, Hong Fang

Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and a wholly owned subsidiary of ORI Capital Holding Inc. Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc. Each of ORI Capital Holding Inc. and ORI Holding II Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited.

Each of the foregoing parties is referred to as a "Reporting Person" and collectively, as the "Reporting Persons."</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The principal business office of each of the Reporting Persons is C/O Room Nos., 4727-34, Sun Hung Kai Centre, 30 Harbour Road, Wanchai, Hong Kong.
</principalBusinessOfficeOrResidenceAddress>
        <citizenship>The citizenship or place of organization of each of the Reporting Persons is set forth on such Reporting Person's cover page. </citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>The information set forth in rows 5 through 11 of the cover pages to this Schedule 13G is incorporated by reference. The reported percentages are based upon 76,037,858 shares of Common Stock outstanding as of December 16, 2024, as disclosed in the Issuer's Form 424B4 Prospectus filed by the Company on December 13, 2024 based on the number of shares of Common Stock to be outstanding if the underwriters exercised their option to purchase additional shares of Common Stock in full.

Unique Diamond Investments Limited directly owns 586,982 shares of Common Stock, which represents approximately 0.8% of the outstanding shares of Common Stock, and Charming Jade Limited directly owns 3,003,931 shares of Common Stock, which represents approximately 4.0% of the outstanding shares of Common Stock. Unique Diamond Investments Limited is a wholly-owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and may be deemed to have voting, investment and dispositive power with respect to these securities. ORI Capital Inc. is a wholly-owned subsidiary of ORI Capital Holding Inc, which is a wholly-owned subsidiary of Healthcare Seed Limited. Charming Jade Limited is a wholly-owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and may be deemed to have voting, investment and dispositive power with respect to these securities. ORI Capital II Inc. is a wholly-owned subsidiary of ORI Holding II Inc., which is a wholly-owned Subsidiary of Healthcare Seed Limited. Healthcare Seed Limited, as a result, may be deemed to beneficially own 3,590,913 shares of Common Stock held by Unique Diamond Investments Limited and Charming Jade Limited, which represents approximately 4.7% of the outstanding shares of Common Stock. As the sole owner of Healthcare Seed Limited, Ms. Song may be deemed to beneficially own 4,211,341 shares of Common Stock, which includes 613,928 shares of Common Stock held directly by Ms. Song and 6,500 shares of Common Stock underlying options held by Ms. Song that are exercisable as of December 31, 2024 or that will become exercisable within 60 days after such date, which represents approximately 5.5% of the outstanding shares of Common Stock.</amountBeneficiallyOwned>
        <classPercent>See above.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>(1) Unique Diamond Investments Limited: 586,982 shares of Common Stock;
(2) ORI Healthcare Fund, L.P.: 586,982 shares of Common Stock;
(3) ORI Capital Inc.: 586,982 shares of Common Stock;
(4) ORI Capital Holding Inc.: 586,982 shares of Common Stock;
(5) Charming Jade Limited: 3,003,931 shares of Common Stock;
(6) ORI Healthcare Fund II, L.P.: 3,003,931 shares of Common Stock;
(7) ORI Capital II Inc.: 3,003,931 shares of Common Stock;
(8) ORI Holding II Inc.: 3,003,931 shares of Common Stock;
(9) Healthcare Seed Limited: 3,590,913 shares of Common Stock; and
(10) SONG, Hong Fang: 4,211,341 shares of Common Stock.

</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>None.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>(1) Unique Diamond Investments Limited: 586,982 shares of Common Stock;
(2) ORI Healthcare Fund, L.P.: 586,982 shares of Common Stock;
(3) ORI Capital Inc.: 586,982 shares of Common Stock;
(4) ORI Capital Holding Inc.: 586,982 shares of Common Stock;
(5) Charming Jade Limited: 3,003,931 shares of Common Stock;
(6) ORI Healthcare Fund II, L.P.: 3,003,931 shares of Common Stock;
(7) ORI Capital II Inc.: 3,003,931 shares of Common Stock;
(8) ORI Holding II Inc.: 3,003,931 shares of Common Stock;
(9) Healthcare Seed Limited: 3,590,913 shares of Common Stock; and
(10) SONG, Hong Fang: 4,211,341 shares of Common Stock.
</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>None.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Unique Diamond Investments Limited</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang/Director</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ORI Healthcare Fund, L.P.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang/Director</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ORI Capital Inc.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang/Director</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ORI Capital Holding Inc.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang/Director</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Charming Jade Limited</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang/Director</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ORI Healthcare Fund II, L.P.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang/Director of General Partner</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ORI Capital II Inc.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang/Director</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>ORI Holding II Inc.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang/Director</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Healthcare Seed Limited</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang/Director</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>SONG, Hong Fang</reportingPersonName>
      <signatureDetails>
        <signature>/s/ SONG, Hong Fang</signature>
        <title>SONG, Hong Fang</title>
        <date>01/28/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
